Cynata Therapeutics
ASX:CYP
$ 0,30
+ $0,01 (3,45%)
0,30 $
+$0,01 (3,45%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,05
Earnings Per Share
$0,01
Revenue Per Share
0,00%
Operating Margin %
$0,07 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-0,05
Revenue Per Share
$0,01
Operating Margin %
0,00%
Market Cap
$0,07 B
Long-Term Debt
$0,00 B

Financials

Year Year 2025 2024 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share $-0,05 $-0,05 $-0,03 $-0,08 $-0,05 $-0,06 $-0,07 $-0,06
Earnings Earnings $-11,87M $-9,03M $-3,51M $-8,16M $-4,75M $-5,40M $-5,09M $-3,96M
RPS Revenue Per Share $0,01 $0,01 $0,06 $0,02 $0,00 $0,02 $0,02 $0,01
Revenue Revenue $1,89M $2,32M $7,15M $1,57M $0,14M $1,84M $1,25M $0,37M
OCF Operating Cash Flow $-8,72M $-9,96M $-3,39M $-6,76M $-4,06M $-4,05M $0,00M $0,00M
FCF Free Cash Flow $-8,77M $-9,96M $0,00M $-6,76M $-4,06M $-4,05M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% -49,93% 0,00% 0,00% -262,09% 0,00% 0,00%
GM % Gross Margin % 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00%
FCFS Free Cash Flow Per Share $-0,04 $-0,06 $-0,03 $-0,07 $-0,04 $-0,05 $-0,06 $-0,04
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 237,45M 180,55M 117,12M 102,04M 95,07M 90,06M 72,74M 66,07M
×